Home/Filings/8-K/0001493152-26-001234
8-K//Current report

Microbot Medical Inc. 8-K

Accession 0001493152-26-001234

$MBOTCIK 0000883975operating

Filed

Jan 11, 7:00 PM ET

Accepted

Jan 12, 8:30 AM ET

Size

246.6 KB

Accession

0001493152-26-001234

Research Summary

AI-generated summary of this filing

Updated

Microbot Medical Inc. Announces 2026 Milestones, Reaffirms 2025 Achievements

What Happened

  • On January 12, 2026, Microbot Medical Inc. (MBOT) filed a Form 8-K to furnish a press release that reaffirms the company’s 2025 achievements and announces key anticipated milestones for 2026. The press release is incorporated by reference and furnished as Exhibit 99.1. The release includes forward‑looking statements.

Key Details

  • Filing date: January 12, 2026 (Form 8‑K, Item 8.01).
  • Content: Reaffirmation of 2025 achievements and announcement of anticipated 2026 milestones (details provided in the press release).
  • Exhibit: Press release furnished as Exhibit 99.1 to the Form 8‑K.
  • No financial statements, earnings, executive changes, or material agreements were reported in this filing.

Why It Matters

  • This filing is an informational update: it signals management’s view of past progress (2025) and outlines planned near‑term goals (2026) that could be catalysts if achieved.
  • Because the release contains forward‑looking statements, investors should treat milestone timelines and expectations as projections subject to risks and uncertainties.
  • Retail investors should read the Exhibit 99.1 press release for the specific milestones and monitor future filings or announcements for material updates or results tied to those milestones.